SMARCB1 and embryonal neoplasm: We detected canonical SMARCB1/SMARCA4 deletions or inactivating mutations in atypical teratoid rhabdoid tumors (ATRTs; Table S2) and C19MC amplification in ETMRs (displayed within “other embryonal tumors” in Figure 2B).26